Drug-eluting stent thrombosis: current and future perspectives

Shoichi Kuramitsu(Kokura Memorial Hospital), Takeshi Kimura(Kyoto University), Yasuhiro Honda(Stanford University), Kenji Andò(Kokura Memorial Hospital), Kazushige Kadota(Kurashiki Central Hospital), Masahiro Natsuaki(Saga University), Reo Anai(University of Occupational and Environmental Health Japan), Shinjo Sonoda(University of Occupational and Environmental Health Japan), Yoshio Kobayashi(Chiba University), Hiromasa Otake(Kobe University)
Cardiovascular Intervention and Therapeutics
January 13, 2021
10.1007/s12928-021-00754-x
Cited by 80

Related Papers

Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies
|Journal of the American College of Cardiology|2012|1.8k
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|830
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
|Thrombosis and Haemostasis|2020|334
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|296